NewsDesk  @infectiousdiseasenews A new Cornell study has found the antimicrobial properties of certain stem cell proteins could offer a potential treatment to reduce infection in skin wounds. Treating...

NewsDesk  @infectiousdiseasenews Australia’s Therapeutic Goods Administration (TGA) placed new restrictions on the prescribing of oral ivermectin, according to an announcement last Friday. General...

NewsDesk  @infectiousdiseasenews the customs units of the Ministry of Health which are responsible for the evaluation of specific requests for the importation of medicines from abroad, the Italian Medicines...

NewsDesk @bactiman63 With a rise in calls to poison control centers and visits to emergency rooms, the Kansas Department of Health and Environment (KDHE) is urging Kansans not to take the drug ivermectin...

By NewsDesk @bactiman63 The U.S. Food and Drug Administration (FDA) and other health agencies have advised against the unauthorized use of the drug ivermectin to treat or prevent COVID-19 in humans. The...

By NewsDesk @bactiman63 Florida Poison Control tweeted last week that they are seeing a spike in cases related to ivermectin, a deworming medication. They report treating 27 patients in August, primarily...

By NewsDesk @bactiman63 Ivermectin is a U.S. Food and Drug Administration (FDA)-approved prescription medication used to treat certain infections caused by internal and external parasites. During the...

By NewsDesk @bactiman63 Boston-based biopharmaceutical company, Paratek Pharmaceuticals announced the novel, once-daily oral and intravenous antibiotic NUZYRA® (omadacycline) has recently been added...

Only 21 percent of patients with severe pneumonia caused by SARS-CoV-2 (the virus that causes COVID-19) have a documented bacterial superinfection at the time of intubation, resulting in potential overuse...

By NewsDesk  @infectiousdiseasenews The US Food and Drug Administration (FDA) put out a tweet Saturday that has garnered a lot of attention (with 36.6K retweets as of this writing) which states: You...